Provided by Tiger Trade Technology Pte. Ltd.

KINTOR PHARMA-B

1.740
-0.020-1.14%
Volume:366.00K
Turnover:639.84K
Market Cap:868.26M
PE:-3.35
High:1.795
Open:1.790
Low:1.720
Close:1.760
52wk High:4.700
52wk Low:1.600
Shares:499.00M
HK Float Shares:499.00M
Volume Ratio:0.64
T/O Rate:0.07%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.519
ROE:-118.45%
ROA:-30.31%
PB:6.82
PE(LYR):-3.35
PS:9.46

Loading ...

Kintor Pharma outlines progress on audit-related remediation, targets KX-826 NDA in 2H26, secures RMB100 million new credit

Bulletin Express
·
Jul 31

Guangzhou Xinji Medical Files Second Hong Kong IPO Application: Emerging Clinical and Governance Challenges

Deep News
·
Jul 31

Indian equities rebound after AI-driven selloff; IT stocks surge while banking, power, and pharma sectors attract investment

Stock News
·
Jul 31

Clinical Progress Accelerates, But Cash Burn Remains the Unanswered Question for 18A Biotech Innovator

Stock News
·
Jul 31

New regulations arriving in August 2026: Key changes affecting your daily life

Deep News
·
Jul 31

New Regulations Taking Effect in Sichuan and Nationwide Starting August 2026

Deep News
·
Jul 30

Probe into New Listings: Can Puqi Pharma Cross the Commercialization Gap with 'Local Delivery' in the JAK Inhibitor Blue Ocean?

Stock News
·
Jul 30

Moutai's resurgence drives capital rotation into baijiu sector; bank ETF surges 2.5% as defensive plays gain traction, while healthcare shows resilience

Deep News
·
Jul 30

Healthcare Stocks Show Resilience From Low Levels, Consumer Medical Rises, Traditional Chinese Medicine Shares Rally

Deep News
·
Jul 30

ALEBUND-B (09637) Issued 8.51 Million Shares Following Full Exercise of Over-Allotment Option

Stock News
·
Jul 29

Is Spring on the Horizon for Healthcare? Ge Lan Leads Market Gains

Deep News
·
Jul 29

3D Medicines Achieves Complete Arbitration Victory, Pushing Forward 3D189 Development in Greater China

Stock News
·
Jul 29

Changxin Technology's IPO Marks the Final Turning Point for Pharmaceutical Stocks

Deep News
·
Jul 27

TYK Medicines-B Shares Surge Over 5% as Qilu Pharma Secures Exclusive Rights for Lung Cancer Drug TY-9591

Deep News
·
Jul 27

Pharmaceutical Sector Poised to Become a Market Leader, as Innovation Drugs and CRO See Structural Opportunities

Deep News
·
Jul 27

Bridging Real-World Research and Health Economics: The "Boya Hui - Evidence-Based China Tour" Kunming Symposium Successfully Concludes

Deep News
·
Jul 26

University graduates pursue vocational training as Shandong college launches specialized technician classes

Deep News
·
Jul 25

Tencent Holdings Boosts Stake in ALEBUND-B with 238,500 Share Purchase

Stock News
·
Jul 23

Dizal Pharmaceutical Anticipates First-Half Net Loss of Approximately 2.1 Billion Yuan

Stock News
·
Jul 23

Dizal Pharmaceutical's Hong Kong IPO Prospectus Lapses

Stock News
·
Jul 23